Your browser doesn't support javascript.
loading
Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye
Tekinalp, Atakan; Gedük, Ayfer; Akdeniz, Aydan; Terzi Demirsoy, Esra; Gürsoy, Vildan; Aslaner Ak, Müzeyyen; Bagci, Metin; Seçilmis, Sema; Keklik Karadag, Fatma; Oruç Uysal, Ayse; Dogan, Ali; Demircioglu, Sinan; Erol, Hasim Atakan; Aslan, Ceyda; Özkalemkas, Fahir; Ertop, Sehmus; Dagli, Mehmet; Dal, Mehmet Sinan; Saydam, Güray; Merter, Mustafa; Ural, Cihan; Çeneli, Özcan.
Afiliação
  • Tekinalp A; Necmettin Erbakan University Meram Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye
  • Gedük A; Kocaeli University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Kocaeli, Türkiye
  • Akdeniz A; Mersin University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Mersin, Türkiye
  • Terzi Demirsoy E; University of Health Sciences Türkiye, Derince Training and Research Hospital, Clinic of Hematology, Kocaeli, Türkiye
  • Gürsoy V; Bursa City Hospital, Clinic of Hematology, Bursa, Türkiye
  • Aslaner Ak M; Bülent Ecevit University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Zonguldak, Türkiye
  • Bagci M; Selçuk University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye
  • Seçilmis S; Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Hematology, Ankara, Türkiye
  • Keklik Karadag F; Ege University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Izmir, Türkiye
  • Oruç Uysal A; Firat University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Elazig, Türkiye
  • Dogan A; Van Yüzüncü Yil University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Van, Türkiye
  • Demircioglu S; Necmettin Erbakan University Meram Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye
  • Erol HA; Kocaeli University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Kocaeli, Türkiye
  • Aslan C; University of Health Sciences Türkiye, Derince Training and Research Hospital, Clinic of Hematology, Kocaeli, Türkiye
  • Özkalemkas F; Bursa Uludag University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Bursa, Türkiye
  • Ertop S; Bülent Ecevit University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Zonguldak, Türkiye
  • Dagli M; Selçuk University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye
  • Dal MS; Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Clinic of Hematology, Ankara, Türkiye
  • Saydam G; Ege University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Izmir, Türkiye
  • Merter M; Firat University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Elazig, Türkiye
  • Ural C; Van Yüzüncü Yil University Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Van, Türkiye
  • Çeneli Ö; Necmettin Erbakan University Meram Faculty of Medicine, Department of Hematology, Division of Internal Medicine, Konya, Türkiye
Turk J Haematol ; 40(4): 242-250, 2023 12 05.
Article em En | MEDLINE | ID: mdl-37961952
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article